TSLA vs URGN · P/E 179, rev $94.83B vs rev $109.8M
Tesla Inc (TSLA) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon R. Musk.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
TSLA currently screens at market cap $976.12B and trailing P/E 179.1. URGN currently screens at market cap $1.61B.
Not investment advice. Open the TSLA and URGN stock pages for the full models.
Not investment advice.